Compare
Medpace vs Agilent Technologies
MonkScore ranges and fundamentals, side by side
Key facts
Medpace and Agilent Technologies: key facts
- In fiscal 2025, Medpace Holdings, Inc. reported revenue of $2.5B and net income of $451.1M.
- In fiscal 2025, Agilent Technologies, Inc. reported revenue of $6.9B and net income of $1.3B.
- Medpace Holdings, Inc.'s revenue grew 22.0% a year from fiscal 2021 to fiscal 2025.
- Agilent Technologies, Inc.'s revenue grew 2.4% a year from fiscal 2021 to fiscal 2025.
- Medpace Holdings, Inc.'s free cash flow was positive in 5 of the 5 fiscal years from 2021 to 2025.
- Agilent Technologies, Inc.'s free cash flow was positive in 5 of the 5 fiscal years from 2021 to 2025.
- In the twelve months to 30 September 2026, Medpace Holdings, Inc. reported revenue of $2.8B and net income of $517.8M.
- In the twelve months to 31 July 2026, Agilent Technologies, Inc. reported revenue of $7.4B and net income of $1.4B.
Side by side
Medpace and Agilent Technologies, side by side
Each figure is in the company's reporting currency, with its fiscal year or the date of its last report.
| Figure | Medpace Holdings, Inc.NASDAQ:MEDP | Agilent Technologies, Inc.NYSE:A |
|---|---|---|
| MonkScore | ||
| MonkScore range | 90–100as of October 2026 | 70–80as of October 2026 |
| Sector rank | 4 of 628 in Healthcare | 146 of 628 in Healthcare |
| How this score is madeDisclaimer | ||
| Profile | ||
| Sector | Healthcare | Healthcare |
| Industry | Medical - Diagnostics & Research | Medical - Diagnostics & Research |
| Latest fiscal year | ||
| Revenue | $2.5BFY 2025 | $6.9BFY 2025 |
| Net income | $451.1MFY 2025 | $1.3BFY 2025 |
| Free cash flow | $681.9MFY 2025 | $1.2BFY 2025 |
| Operating cash flow | $713.2MFY 2025 | $1.6BFY 2025 |
| Total debt | $136.9MFY 2025 | $3.4BFY 2025 |
| Cash | $497.0MFY 2025 | $1.8BFY 2025 |
| Last 12 months | ||
| Revenue | $2.8Bto 30 September 2026 | $7.4Bto 31 July 2026 |
| Net income | $517.8Mto 30 September 2026 | $1.4Bto 31 July 2026 |
| Free cash flow | $667.6Mto 30 September 2026 | $1.4Bto 31 July 2026 |
| Operating cash flow | $723.0Mto 30 September 2026 | $1.6Bto 31 July 2026 |
| Total debt | $146.0Mto 30 September 2026 | $3.9Bto 31 July 2026 |
| Cash | $705.3Mto 30 September 2026 | $1.8Bto 31 July 2026 |
Company pages
Each company on its own
MonkStreet provides research, not investment advice.